港通医疗: 第五届董事会第五次会议决议公告

Group 1 - The company held its fifth board meeting on September 3, 2025, with all nine directors present, confirming the meeting's legality and effectiveness [1][2] - The board approved a proposal to jointly invest in a fund with professional investment institutions, establishing the Chengdu Rongchuang Gangtong Equity Investment Fund Partnership with a total subscription amount of RMB 500 million [1][2] - The company will contribute RMB 150 million as a limited partner, representing 30% of the total fund subscription [2]